Academic Research Lab
PI-led · 4–15 members · R01/R21 funded
A wet-lab PI group with strong biology and limited computational capacity. The lab generates sequencing data faster than the team can analyze it - one or two graduate students handle bioinformatics, but complex assays (Ribo-Seq, m6A, Nanopore) require external expertise.
pipeline dev
stat analysis
pub figures
methods writing
[organism: H.sapiens]
[assay: RNA-Seq/Ribo-Seq]
[tissue: various]
[instrument: Illumina NovaSeq 6000]
[layout: PAIRED]
Biotech Startup
Series A/B · 10–50 employees · VC-backed
A pre-clinical or early-clinical biotech needing bioinformatics capacity without the cost of a full-time senior hire. Genomics data informs the drug target or therapeutic hypothesis. Speed and reproducibility are both critical - IND filings and investor decks have firm deadlines.
target discovery
biomarker analysis
cloud infra
retainer
[organism: H.sapiens / Mus musculus]
[assay: scRNA-Seq / WGS]
[source: primary tissue / cell line]
[treatment: compound_vs_vehicle]
Pharma R&D
Enterprise · 500+ employees · late-stage pipeline
A large pharma organization supplementing internal bioinformatics capacity with specialized external expertise. May require HIPAA compliance, BAA documentation, and validated methods. OmicsEdge fills gaps in rare-assay domains (TERA-Seq, Nanopore methylation) where internal teams lack depth.
rare assays
HIPAA / BAA
validated methods
ML models
[organism: H.sapiens]
[assay: TERA-Seq / m6A-Seq]
[compliance: HIPAA]
[phi: de-identified]
[data_tier: tier-3-secure]
Clinical Genomics
Hospital / diagnostic lab · regulated environment
A clinical genomics unit at a hospital or diagnostic laboratory running population-scale variant analysis, tumor-normal WGS, or long-read sequencing for structural variant calling. Regulatory constraints are real - pipelines need validated parameters, audit trails, and documented QC thresholds.
WGS / WES
SV calling
audit trail
HIPAA BAA
[organism: H.sapiens]
[assay: WGS / WES / ONT-SV]
[instrument: ONT PromethION / Illumina]
[HIPAA: required]
HPC → Cloud Migration
Core facility / institution · legacy infrastructure
A genomics core facility or institution moving from on-premise HPC (SLURM/PBS) to cloud-native infrastructure. Legacy pipelines need containerization, workflow re-engineering, and cost modeling. OmicsEdge provides Terraform infrastructure-as-code and modernized Snakemake/Nextflow implementations.
Terraform
Docker / Singularity
AWS Batch
cost modeling
[infrastructure: HPC-to-AWS]
[scheduler: SLURM → Batch]
[container: Docker/Singularity]
[iac: Terraform]
Grant-Funded Investigator
PI-independent · NIH / NSF / DoD funding
A recently funded investigator (new-to-independent) or established PI needing preliminary data for an upcoming grant renewal. Tight timelines dictated by submission deadlines. OmicsEdge produces analysis-ready results and publication-quality figures matched to reviewer expectations at NIH study sections.
prelim data
grant figures
deadline-driven
methods text
[funding: NIH R01 / R21 / NSF]
[assay: varies by aim]
[deadline: submission-locked]
[output: fig + methods_text]
Is OmicsEdge the right fit?
✓
Good fit: You have sequencing data and a biological question but limited bioinformatics capacity. You need results, not training wheels.
✓
Good fit: The assay is unusual - Ribo-Seq, TERA-Seq, long-read, m6A - and off-the-shelf pipelines don't capture your experimental design.
✓
Good fit: You have a hard deadline - paper submission, grant due date, IND filing - and need someone who can deliver on schedule.
~
Case-by-case: Large-scale population genomics (>500 samples) or continuous production pipelines may benefit from a larger team. Reach out to discuss.
✗
Not a fit: You need an on-site FTE embedded in your lab full-time. OmicsEdge operates as a remote consultancy, not a staff augmentation service.